EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers

Letizia Crocetti iD, Maria Paola Giovannoni, Gabriella Guerrini iD, Silvia Lamanna, Fabrizio Melani, Gianluca Bartolucci iD, Marco Pallecchi iD, Paola Paoli iD, Martina Lippi, Junjie Wang, Gerhard Dahl iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Letizia Crocetti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Neurofarba, Pharmaceutical and Nutraceutical Section, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy. Hauptthemen laut MEDLINE: Neuralgia, Quinolines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pannexins are an interesting new target in medicinal chemistry, as they are involved in many pathologies such as epilepsy, ischemic stroke, cancer and Parkinson’s disease, as well as in neuropathic pain. They are a family of membrane channel proteins consisting of three members, Panx-1, Panx-2 and Panx-3, and are expressed in vertebrates. In the present study, as a continuation of our research in this field, we report the design, synthesis and pharmacological evaluation of new quinoline-based Panx-1 blockers. The most relevant compounds 6f and 6g show an IC50 = 3 and 1.5 µM, respectively, and are selective Panx-1 blockers. Finally, chemical stability, molecular modelling and X-ray crystallography studies have been performed providing useful information for the realization of the project.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaQuinolinesAnimalsHumansModels, MolecularConnexinsNerve Tissue Proteins

Stichwörter der Autor:innen

X-ray crystallographychemical stabilitymolecular modelingpannexinspanx-1 blockersquinolinesquinolones

Substanzen

QuinolinesConnexinsNerve Tissue Proteins

Autor:innen und Institutionen

  • Neurofarba, Pharmaceutical and Nutraceutical Section, University of Florence, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy.
  • Department of Industrial Engineering, University of Florence, Via S. Marta 3, 50136 Florence, Italy.
  • Department of Physiology and Biophysics, School of Medicine, University of Miami, 1600 N.W. 10th Avenue, Miami, FL 33136, USA.

ORCID-Profile: Letizia Crocetti, Gabriella Guerrini, Gianluca Bartolucci, Marco Pallecchi, Paola Paoli, Gerhard Dahl

Zitieren

APA

Crocetti, L., Giovannoni, M. P., Guerrini, G., Lamanna, S., Melani, F., Bartolucci, G., Pallecchi, M., Paoli, P., Lippi, M., Wang, J., & Dahl, G. (2023). Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032022

Vancouver

Crocetti L, Giovannoni MP, Guerrini G, Lamanna S, Melani F, Bartolucci G, et al. Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032022

BibTeX
@article{Crocetti2023,
  author = {Crocetti, Letizia and Giovannoni, Maria Paola and Guerrini, Gabriella and Lamanna, Silvia and Melani, Fabrizio and Bartolucci, Gianluca and Pallecchi, Marco and Paoli, Paola and Lippi, Martina and Wang, Junjie and Dahl, Gerhard},
  title = {Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032022}
}
Kostenlos starten →